» Articles » PMID: 10365839

Correlation Between DNA Content and P53 Deletion in Colorectal Cancer

Overview
Journal Eur J Surg
Specialty General Surgery
Date 1999 Jun 12
PMID 10365839
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To find out whether tumour DNA content correlates with allelic loss of p53 and other pathological features in primary colorectal carcinomas.

Design: Ongoing prospective study.

Setting: University hospital, Italy.

Subjects: 128 patients who had undergone radical resections for colorectal carcinoma.

Interventions: Flow cytometric measurement of tumour DNA content and detection of allelic loss on the short arm of chromosome 17 by Southern blot (restriction fragment length polymorphism) analysis in fresh tumour specimens.

Main Outcome Measures: Correlation between DNA ploidy and deletion of p53, as well as between these two genetic events and clinicopathological variables.

Results: Interpretable DNA histograms were obtained for 122 tumour specimens. Forty-three tumours (35%) were diploid and 79 (65%) aneuploid. The diploid tumours were significantly more common in the proximal colon (from the caecum to the splenic flexure) than in the distal colon (from the descending colon to the rectum) (p = 0.002). The allelic state on the short arm of chromosome 17 was evaluated in 80 heterozygous patients. Forty-four tumour specimens (55%) showed deletion of 17p. Allelic loss of p53 was significantly more common in the distal and rectal tumours than in the proximal ones (p < 0.0001). Aneuploidy was more common among those tumours which had shown deletion of p53 than in those that had not (p = 0.0008).

Conclusions: DNA aneuploidy was significantly associated with the deletion of the p53 gene. This suggests that the functional loss of p53 may favour the growth and establishment of an aneuploid cell population within tumours. Tumours of the proximal and distal colon differ in their genetic nature.

Citing Articles

Therapy enhancing chromosome instability may be advantageous for gliomas.

Goncharov N, Baklanov I, Gulaia V, Shuliak A, Lanskikh D, Zhmenia V NAR Cancer. 2025; 7(1):zcaf003.

PMID: 39949830 PMC: 11822378. DOI: 10.1093/narcan/zcaf003.


FILIP1L Loss Is a Driver of Aggressive Mucinous Colorectal Adenocarcinoma and Mediates Cytokinesis Defects through PFDN1.

Kwon M, Rubio G, Nolan N, Auteri P, Volmar J, Adem A Cancer Res. 2021; 81(21):5523-5539.

PMID: 34417201 PMC: 8563430. DOI: 10.1158/0008-5472.CAN-21-0897.


On the role of p53 in the cellular response to aneuploidy.

Narkar A, Johnson B, Bharne P, Zhu J, Padmanaban V, Biswas D Cell Rep. 2021; 34(12):108892.

PMID: 33761356 PMC: 8051136. DOI: 10.1016/j.celrep.2021.108892.


BCL9L Dysfunction Impairs Caspase-2 Expression Permitting Aneuploidy Tolerance in Colorectal Cancer.

Lopez-Garcia C, Sansregret L, Domingo E, McGranahan N, Hobor S, Birkbak N Cancer Cell. 2017; 31(1):79-93.

PMID: 28073006 PMC: 5225404. DOI: 10.1016/j.ccell.2016.11.001.


Detection of replicative integrity in small colonic biopsies using the BrdUrd comet assay.

McGlynn A, Wasson G, OReilly S, McKelvey-Martin V, McNulty H, Strain J Br J Cancer. 2003; 88(6):895-901.

PMID: 12644827 PMC: 2377088. DOI: 10.1038/sj.bjc.6600836.